《Biodrugs》是一本由ADIS INT LTD出版商出版的专业医学期刊，该刊创刊于1994年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：免疫学 3区；肿瘤学 3区；药学 3区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖免疫学等领域，旨在及时、准确、全面地报道国内外免疫学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为7.744，平均审稿速度>12周，或约稿。

Biodrugs英文介绍

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager?, supported by a database of international experts. This database is shared with other Adis journals.

Biodrugs中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	PHARMACOLOGY & PHARMACY 药学 IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学	2区 3区 3区	否	否

Biodrugs期刊近9年JCR分区变化趋势

BiodrugsJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q1	ONCOLOGY	Q1	7.744
	PHARMACOLOGY & PHARMACY	Q1
	IMMUNOLOGY	Q1

Biodrugs期刊近7年影响因子变化趋势

Biodrugs期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
10.50	1.539	1.740	大类：Medicine 小类：Pharmacology (medical)	Q1	12 / 255	95%
			大类：Medicine 小类：Pharmacology	Q1	25 / 303	91%
			大类：Medicine 小类：Biotechnology	Q1	30 / 293	89%

Biodrugs期刊近7年自引率变化趋势

上周TOP10